Oncolytics Biotech Inc.

447 articles with Oncolytics Biotech Inc.

• Oncolytics Biotech Inc. Announces Details Of 2016 Annual Meeting Of Shareholders

  5/3/2016

• Oncolytics Biotech Inc. To Participate In The Bloom Burton & Co. Healthcare Investor Conference

  4/29/2016

• Oncolytics Biotech Inc. Announces Formation Of Science And Technology Committee

  4/29/2016

• Oncolytics Biotech Inc. Collaborators Present REOLYSIN Preclinical Research At The 2016 AACR Annual Meeting

  4/18/2016

• Oncolytics Biotech Inc. Reports Updated Data From Randomized Phase 2 Study Of REOLYSIN In Pancreatic Cancer

  4/14/2016

• Oncolytics Biotech Inc. Announces Filing Of Management Information Circular And Details Of 2016 Annual General Meeting

  3/28/2016

• Oncolytics Biotech Inc. Announces 2015 Year End Results

  3/11/2016

• Oncolytics Biotech Inc. Announces First Patients Treated In Phase 1b Study In Advanced Pancreatic Cancer

  1/20/2016

• Oncolytics Biotech Inc. Announces First Patients Treated In Phase 1b Study In Advanced Pancreatic Cancer

  1/19/2016

• Oncolytics Biotech Inc. Collaborators Present Multiple Myeloma Data At 57th American Society of Hematology Annual Meeting

  12/8/2015

• MEDIA ADVISORY - Oncolytics Biotech Inc. To Present At LD Micro Growth Conference

  12/2/2015

• Oncolytics Biotech Inc. Announces Start Of Enrollment In Phase 1b Study Of Multiple Myeloma Looking At REOLYSIN In Combination With Bortezomib

  11/18/2015

• Oncolytics Biotech Inc. Announces 2015 Third Quarter Results

  11/5/2015

• Oncolytics Biotech Inc. Announces Receipt Of Qualification For Trading On The OTCQX And Nasdaq Notice Of Delisting

  10/29/2015

• Oncolytics Biotech Inc. Announces Phase 1b Study In Advanced Pancreatic Cancer

  10/20/2015

• Media Advisory - Oncolytics Biotech Inc. To Participate In The 14th Annual BIO Investor Forum

  10/20/2015

• Oncolytics Biotech Inc. Announces Completion Of Enrollment In Randomized Phase II Prostate Cancer Study

  10/6/2015

• Oncolytics Biotech Inc. Collaborators Present Data From Clinical Study In Multiple Myeloma

  9/28/2015

• Media Advisory - Oncolytics Biotech Inc. To Participate In The Baird 2015 Healthcare Conference

  9/9/2015

• Oncolytics Biotech Inc. Collaborators To Present Survival Data From REO 016 Study In Non-Small Cell Lung Cancer

  8/27/2015